Development of a Fluorescent Assay and Imidazole-Containing Inhibitors by Targeting SARS-CoV-2 Nsp13 Helicase
Molecules · 2024
DOI: 10.3390/molecules29102301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Chuang Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Med…. Hauptthemen laut MEDLINE: Antiviral Agents, Imidazoles, SARS-CoV-2, Viral Nonstructural Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GUIZHOU SCIENCE AND TECHNOLOGY DEPARTMENT OF CHINA.
Abstract (Originalsprache)
Nsp13, a non-structural protein belonging to the coronavirus family 1B (SF1B) helicase, exhibits 5′–3′ polarity-dependent DNA or RNA unwinding using NTPs. Crucially, it serves as a key component of the viral replication–transcription complex (RTC), playing an indispensable role in the coronavirus life cycle and thereby making it a promising target for broad-spectrum antiviral therapies. The imidazole scaffold, known for its antiviral potential, has been proposed as a potential scaffold. In this study, a fluorescence-based assay was designed by labeling dsDNA substrates with a commercial fluorophore and monitoring signal changes upon Nsp13 helicase activity. Optimization and high-throughput screening validated the feasibility of this approach. In accordance with the structural characteristics of ADP, we employed a structural-based design strategy to synthesize three classes of imidazole-based compounds through substitution reaction. Through in vitro activity research, pharmacokinetic parameter analysis, and molecular docking simulation, we identified compounds A16 (IC50 = 1.25 μM) and B3 (IC50 = 0.98 μM) as potential lead antiviral compounds for further targeted drug research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Provincial Key Laborato…
- School of Basic Medical Science, Guizhou Medical University, Guiyang 550004, China.
Förderung
- GUIZHOU SCIENCE AND TECHNOLOGY DEPARTMENT OF CHINA
Zitieren
APA
Zhang, C., Yu, J., Deng, M., Zhang, Q., Jin, F., Chen, L., Li, Y., & He, B. (2024). Development of a Fluorescent Assay and Imidazole-Containing Inhibitors by Targeting SARS-CoV-2 Nsp13 Helicase. Molecules. https://doi.org/10.3390/molecules29102301
Vancouver
Zhang C, Yu J, Deng M, Zhang Q, Jin F, Chen L, et al. Development of a Fluorescent Assay and Imidazole-Containing Inhibitors by Targeting SARS-CoV-2 Nsp13 Helicase. Molecules. 2024. doi:10.3390/molecules29102301
BibTeX
@article{Zhang2024,
author = {Zhang, Chuang and Yu, Junhui and Deng, Mingzhenlong and Zhang, Qingqing and Jin, Fei and Chen, Lei and Li, Yan and He, Bin},
title = {Development of a Fluorescent Assay and Imidazole-Containing Inhibitors by Targeting SARS-CoV-2 Nsp13 Helicase},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29102301}
}
EUVIMED